HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dy-DTPA-BMA as an indicator of tissue viability in MR imaging. An experimental study in the pig.

Abstract
The aim of this study was to investigate whether dysprosium (Dy) induced signal intensity (SI) loss in infarcted tissue in MR imaging. Myocardial infarction was induced in 12 pigs and Dy-DTPA-BMA (1.0 mmol/kg b.w.) was administered i.v. to 6 pigs 4 hours after occlusion and allowed to accumulate in the infarctions for 2 hours. Dy was analysed by inductively coupled plasma atomic emission spectrometry in infarcted and non-ischaemic tissue samples. The remaining 6 pigs, not administered contrast medium, served as controls. The infarctions demonstrated a high SI in the proton density- and T2-weighted sequences in both groups (ex vivo), although the Dy-DTPA-BMA group demonstrated a 3-fold greater concentration of Dy in infarcted compared with non-ischaemic myocardium. The lack of SI loss after Dy accumulation indicates that susceptibility effects are minor or absent in infarcted myocardium.
AuthorsS Nilsson, M Wikström, H J Martinussen, A Ericsson, G Wikström, A Waldenström, A N Oksendal, A Hemmingsson
JournalActa radiologica (Stockholm, Sweden : 1987) (Acta Radiol) Vol. 36 Issue 4 Pg. 338-45 (Jul 1995) ISSN: 0284-1851 [Print] England
PMID7619609 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Organometallic Compounds
  • sprodiamide
  • Dysprosium
  • Pentetic Acid
Topics
  • Analysis of Variance
  • Animals
  • Contrast Media (pharmacokinetics)
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Dysprosium (pharmacokinetics)
  • Female
  • Magnetic Resonance Imaging (instrumentation, methods, statistics & numerical data)
  • Male
  • Myocardial Infarction (blood, diagnosis)
  • Myocardium (pathology)
  • Organometallic Compounds (pharmacokinetics)
  • Pentetic Acid (analogs & derivatives, pharmacokinetics)
  • Swine
  • Time Factors
  • Tissue Survival

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: